Research Highlights New Hope for Protecting Livestock from H5N1 Bird Flu
According to the research conducted by a team from the University of Nebraska–Lincoln, led by Dr. Eric Weaver, Professor of Biological Sciences and Director of the Nebraska Center for Virology. Researchers have developed a promising new vaccine approach to protect livestock against highly pathogenic bird flu, also known as H5N1.
The vaccine has shown strong results in early testing, offering hope to farmers and the agriculture industry.
Bird flu has caused major problems worldwide in recent years. In the United States alone, more than 166 million poultry birds have been culled since 2022 to control outbreaks. In 2024, the virus spread to dairy cattle for the first time, raising serious concerns. Around 70 farm workers also became ill after close contact with infected animals, highlighting risks to human health.
The new vaccine was tested in mice and young dairy calves. Results showed strong immune responses and full protection against severe disease. This is especially important because there are currently no licensed vaccines available to protect cattle from H5N1.
The researchers used a combined vaccination method. One dose was given into muscle to protect the body, while another was delivered through the nose to protect the respiratory system. This two-step method helps prevent both serious illness and animal-to-animal spread.
“I had started working on this as a potential problem in 2005, but the last publication was around 10 years ago,” said Dr. Eric Weaver. “When the outbreak began, my hope was that this would cycle through dairy cattle and be gone, but that didn’t happen. It got progressively worse, and I was worried.”
Calves received their first vaccine at one week of age, followed by a booster four weeks later. Vaccinated mice were also fully protected from deadly exposure to several bird flu strains. These findings suggest the vaccine may work against multiple types of the virus.
Experts believe protecting cattle could reduce financial losses for farmers and lower the chances of the virus spreading further or adapting to humans. The research team is now seeking funding and partnerships to continue testing and possibly develop a vaccine that works across multiple species.
As diseases continue to cross between animals and humans, new solutions like this vaccine platform are becoming more important. This research offers a hopeful step toward stronger farm protection and safer agricultural systems.